Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

TISSUE FACTOR, CYTOKINES, AND SOLUBLE CELL SURFACE RECEPTORS IN RETRANSFUSED UNWASHED SHED BLOOD AND IN SERUM IN TOTAL HIP REPLACEMENT



Abstract

The aim of the study was to look at the concentrations of pro-inflammatory cytokines and soluble cell surface receptors including tissue factor (TF) in the drainage fluid and in the serum after retransfusion. TF is a membranous glycoprotein from the surface of fibroblasts or smooth muscle cells of vessels that functions as a receptor for the coagulation factor VII/VIIa (Kobayashi 1998)

ELISAs were used in twelfve patients to measure the concentrations of interleukins (IL-1β, IL-2, IL-6, IL-8), tumor necrosis factor-a as well as of soluble cell surface receptors (sIL-2Ra, sHLA-DR) and of TF.

All pro-inflammatory cytokines were released into the drainage fluid at increasing concentrations, IL-6 and IL-8 thereby exceeding postoperative systemic blood levels by 200-fold or 80-fold, respectively. Reinfusion of the collected shed blood led to a further increase in both the IL-6 and IL-8 serum concentrations, which were found to be elevated already postoperatively. sHLA-DR was found in an about 100-fold excess vs. serum. The concentration of TF in the drainage fluid was five times higher (158±71 pg/ml) than in serum. There was no increase of the serum of sHLA-DR or TF levels following the retransfusion.

IL-6 and IL-8 seem to be responsible for potential febrile reactions. The 100-fold elevated concentration of sHLA-DR in shed blood could therefore represent a physiological tissue level. The high TF-levels in the shed blood could be related to a local tissue damage. Dilution effects of fluid retransfused may be responsible for minor or no changes of cytokines, soluble cell surface receptors and TF in the circulation